(Q34097284)

31 July 2017

1 reference

title

Current issues in Tourette syndrome (English)

1 reference

31 July 2017

1 reference

Singer HS

1

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

31 July 2017

1 reference

31 July 2017

volume

15

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1051-1063

1 reference

Vomiting and retching in gilles de la tourette syndrome: A report of ten cases and a review of the literature

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

"Signing tics"--insights into the pathophysiology of symptoms in Tourette's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Sign language tics in a prelingually deaf man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Quantitative study of spontaneous eye blinks and eye tics in Gilles de la Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Tourette's Syndrome in Patients Referred for Allergy Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Tourette's syndrome mimicking asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Features Resembling Tourette's Syndrome in Developmental Stutterers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

The temporal dynamics of tics in Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Toward a better definition of the restless legs syndrome. The International Restless Legs Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Periodic limb movements during sleep are a frequent finding in patients with Gilles de la Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Lamotrigine-induced tourettism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Patient perception of tics and other movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Course of Tic Severity in Tourette Syndrome: The First Two Decades

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Stimulant medication withdrawal during long-term therapy in children with comorbid attention-deficit hyperactivity disorder and chronic multiple tic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

The Tourette syndrome diagnostic confidence index: development and clinical associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Bilineal transmission in Tourette syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

The prevalence of Gilles de la Tourette syndrome in children and adolescents with autism: a large scale study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Gilles de la Tourette's syndrome in special education schools: a United Kingdom study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Clinical characteristics of Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Relationship of birth weight to the phenotypic expression of Gilles de la Tourette's syndrome in monozygotic twins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

The inheritance of Gilles de la Tourette's syndrome and associated behaviors. Evidence for autosomal dominant transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Genome scan for linkage to Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Peek-a-boo fragile site at 16d associated with Tourette syndrome, bipolar disorder, autistic disorder, and mental retardation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Identification of genetic markers associated with Gilles de la Tourette syndrome in an Afrikaner population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Nonreplication of linkage disequilibrium between the dopamine D4 receptor locus and Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Do the same genes predispose to Gilles de la Tourette syndrome and dystonia? Report of a new family and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Hypothesis II: Tourette's syndrome is part of a clinical spectrum that includes normal brain development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Investigation of the potential role of genetic imprinting in Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Sex of parent transmission effect in Tourette's syndrome: evidence for earlier age at onset in maternally transmitted cases suggests a genomic imprinting effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Hypothesis: homozygosity in Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Influence of family history on clinical expression of Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Tourette's Syndrome Treated with ACTH and Prednisone: Report of Two Cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

A pilot study of penicillin prophylaxis for neuropsychiatric exacerbations triggered by streptococcal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Therapeutic plasma exchange and intravenous immunoglobulin for obsessive-compulsive disorder and tic disorders in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Antibodies against human putamen in children with Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Tourette's syndrome and 'PANDAS': will the relation bear out? Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Antibodies reacting with cytoplasm of subthalamic and caudate nuclei neurons in chorea and acute rheumatic fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Neurobiology of Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Bilateral globus pallidus lesions in a patient with Tourette syndrome and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Tourette syndrome associated with unilateral cystic changes in the gyrus rectus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Decreased motor inhibition in Tourette's disorder: evidence from transcranial magnetic stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Volumetric MRI changes in basal ganglia of children with Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

A volumetric MRI study of Gilles de la Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Reduced basal ganglia volumes in Tourette's syndrome using three-dimensional reconstruction techniques from magnetic resonance images

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Corpus callosum morphology from magnetic resonance images in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Corpus callosum morphology in children with Tourette syndrome and attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Corpus callosum measurements in girls with Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

A Functional Magnetic Resonance Imaging Study of Tic Suppression in Tourette Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Coexistence of tics and parkinsonism: Evidence for non-dopaminergic mechanisms in tic pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Abnormal dopamine uptake sites in postmortem striatum from patients with tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Tourette syndrome: prediction of phenotypic variation in monozygotic twins by caudate nucleus D2 receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

123Ibeta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Tourette's syndrome: [I-123]beta-CIT SPECT correlates of vocal tic severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Striatal presynaptic monoaminergic vesicles are not increased in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

High presynaptic dopaminergic activity in children with Tourette's disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Serotonin-dopamine antagonist and Gilles de la Tourette's syndrome: an open pilot dose-titration study with risperidone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

The trial use of clozapine for abnormal involuntary movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Cannabinoids: possible role in patho-physiology and therapy of Gilles de la Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

A Double-Blind, Placebo-Controlled, Crossover Trial of an Antiandrogen in the Treatment of Tourette's Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Smoking, nicotine and psychiatric disorders: evidence for therapeutic role, controversies and implications for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Nicotine for the treatment of Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Vocal tics in gilles de la tourette syndrome treated with botulinum toxin injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: effects of stimulant and dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

The effect of central nervous system stimulants on tourette syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Stimulant medications precipitate Tourette's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Motor/vocal tics and compulsive behaviors on stimulant drugs: is there a common vulnerability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

Psychiatric diagnoses in the child and adolescent members of extended families identified through adult bipolar affective disorder probands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200011%2915%3A6%3C1051%3A%3AAID-MDS1001%3E3.0.CO%3B2-L

10.1002/1531-8257(200011)15:6<1051::AID-MDS1001>3.0.CO;2-L

21 January 2018

Identifiers

DOI

1 reference

release_6vyhwqienjgrrgbpj7zjj22dxy

31 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6vyhwqienjgrrgbpj7zjj22dxy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference